Northwest Biotherapeutics Inc share price logo

Northwest Biotherapeutics Inc Share Price

NASDAQ: NWBO

Small Cap

as on

Northwest Biotherapeutics Inc Stock Performance

as on January 1, 1970 at 11:00 am IST

  • $0.20
    $0.22

Northwest Biotherapeutics Inc share price movements today

Previous Close
-
Open
$0.20
Volume
7.1M
Day's Low - High
$0.20 - $0.22

Northwest Biotherapeutics Inc Historical Returns

1 Month Return
+ 0.46 %
3 Month Return
-33.03 %
1 Year Return
-42.92 %
3 Year Return
-62.88 %
5 Year Return
0 %

Northwest Biotherapeutics Inc Stock Fundamentals & Key Indicators

Check Northwest Biotherapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$308.1M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

1.718

Return On Equity TTM

0.00%

Northwest Biotherapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Northwest Biotherapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Northwest Biotherapeutics Inc image
Northwest Biotherapeutics Inc
NA$308.1MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$42.7B130.51%136.818.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.8B98.57%28.4232.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$36.8BNA129.845.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$78.9B48.43%17.9831.41%

Stock Returns calculator for Northwest Biotherapeutics Inc Stock including INR - Dollar returns

The Northwest Biotherapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 10Y

Northwest Biotherapeutics Inc investment value today

Current value as on today

Returns

(0%)

Returns from Northwest Biotherapeutics Inc Stock

(0%)

Dollar Impact

(0%)

Northwest Biotherapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
-13
-
-
-
-
-
-
-
-
-
Operating Income
-13
-13
-15
-15
-17
-14
-18
-17
-14
-14
EBITDA
-12
-
-
-
-
-
-
-
-
-
Interest Expense
1
1
1
1
1
2
2
1
1
2
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-14
-23
-18
-18
-17
-19
-28
-19
-15
-26
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-14
-23
-18
-18
-17
-19
-28
-19
-15
-26
Net Profit Margin
-7188.06%
-5793.60%
-4251.46%
-6447.89%
-3503.73%
-5426.89%
-12217.75%
-5158.13%
-11738.93%
-13414.50%

Northwest Biotherapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
1
0
0
0
2
1
1
1
1
1
Gross Profit
-126
-79
-54
-44
-27
-86
-52
-
-
-
Operating Income
-126
-79
-54
-41
-27
-86
-52
-67
-55
-66
EBITDA
-
-
-67
-24
-17
-520
184
-97
-
-
Interest Expense
-
-
-
9
2
8
5
6
5
7
Depreciation
-
-
0
1
0
0
0
1
1
2
Income Before Tax
-114
-80
-73
-35
-20
-529
179
-105
-62
-83
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-114
-80
-73
-35
-20
-529
179
-105
-62
-83
Net Profit Margin
-6598.10%
-12875.44%
-21768.75%
-8687.86%
-842.16%
-41039.58%
17823.48%
-6240.76%
-3240.11%
-6062.08%

Northwest Biotherapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-18
-18
-17
-19
-28
-19
-15
-26
1
Operating Cash Flow
-16
-12
-16
-8
-20
-9
-6
-13
-14
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
14
12
17
11
15
11
12
11
13
Change in Cash
-3
0
0
0
0
0
1
0
-1

Northwest Biotherapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-73
-35
-20
-529
179
-105
-62
-83
-60
Operating Cash Flow
-36
-34
-31
-32
-38
-52
-53
-57
-44
Investing Cash Flow
0
45
0
-8
-6
-2
-
-
-
Financing Cash Flow
34
7
9
52
48
41
52
56
49
Change in Cash
-1
18
-22
12
3
-8
-4
0
0

Insights on Northwest Biotherapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 131.0K → 200.0K (in $), with an average increase of 34.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 21.1% return, outperforming this stock by 84.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 38.8% return, outperforming this stock by 81.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -15.37M → -26.82M (in $), with an average decrease of 74.5% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, NWBO stock has moved down by -33.0%

About Northwest Biotherapeutics Inc

Northwest Biotherapeutics, Inc., a biotechnology company, focuses on developing personalized immune therapies for cancer. The company develops DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product candidate is the DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, that has completed Phase I clinical trials to treat inoperable solid tumors, as well as a range of types of cancers. Northwest Biotherapeutics, Inc. was founded in 1996 and is headquartered in Bethesda, Maryland.
OrganisationNorthwest Biotherapeutics Inc
Headquarters4800 Montgomery Lane, Bethesda, MD, United States, 20814
IndustryBiotechnology
CEOMs. Linda F. Powers J.D.
E-voting on sharesClick here to vote

Key Management of Northwest Biotherapeutics Inc

Name

Title

Ms. Linda F. Powers J.D.

Chairperson, CEO, President, CFO & Chief Accounting Officer

Dr. Alton L. Boynton Ph.D.

Founder, Chief Scientific Officer, Secretary & Director

Dr. Marnix L. Bosch M.B.A., Ph.D.

Chief Technical Officer

Mr. David Innes

Vice President of Investor Relations

FAQs

What is Northwest Biotherapeutics Inc's market capitalisation today?

Northwest Biotherapeutics Inc market capitalisation is $0.00T as on .

How to invest in Northwest Biotherapeutics Inc Stock (NWBO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Northwest Biotherapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Northwest Biotherapeutics Inc Shares .

What is the minimum amount required to buy Northwest Biotherapeutics Inc Stock (NWBO) from India?

Indian investors can start investing in Northwest Biotherapeutics Inc (NWBO) shares with as little as ₹92.768 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹927.68 in Northwest Biotherapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Learn more about fractional shares .